Neuronetics Announces Pricing of $30 Million Underwritten Public Offering of Common Stock
Neuronetics stock tumbles 10% on stock offering launch
Neuronetics Announces Proposed Public Offering of Common Stock
Neuronetics Announces Credit Agreement Amendments And Public Offering Of Shares; Size Not Disclosed
B. Riley Securities Maintains Buy on Neuronetics, Raises Price Target to $6
Neuronetics Inc (STIM) (Q3 2026) Earnings Call Highlights: Revenue Jumps 12. ...
Neuronetics, Inc. (STIM) Q3 2026 Earnings Call Transcript
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Neuronetics Q3 Earnings Call Highlights
Neuronetics, Inc. Q3 2026 Earnings Call Summary
Neuronetics (STIM) Q3 2026 Earnings Call Transcript
Neuronetics Reports 12.5% Revenue Growth to $42 Million in Q3 2026 as Losses Narrow
Neuronetics (STIM) Reports Q3 Loss, Tops Revenue Estimates
Neuronetics: Q3 Earnings Snapshot
Neuronetics Reports Third Quarter 2026 Financial and Operating Results
Neuronetics Q3 2026 Earnings Call Transcript
Neuronetics Q3 EPS $(0.02) Beats $(0.09) Estimate, Sales $41.962M Beat $40.425M Estimate
Neuronetics Affirms FY2026 Sales Guidance of $160.000M-$164.000M vs $162.025M Est
Neuronetics to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call
BTIG Reiterates Buy on Neuronetics, Maintains $6 Price Target
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.